Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701505 · ClinicalTrials.gov registry record · Phase 2
Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
A Phase 2 study of Anesthesia, sponsored by St. Renatus.
- Completed
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT01701505: Completed Phase 2 study of Anesthesia, sponsored by St. Renatus.
NCT01701505 is a Phase 2 study of Anesthesia that has completed, run by St. Renatus. The registered enrollment target is 48 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01701505, a Phase 2 study of Anesthesia, has completed, sponsored by St. Renatus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the efficacy and safety of intranasally administered Kovacaine Mist for anesthetizing maxillary teeth in pediatric subjects.
Primary Outcome
If the participant does not have sufficient anesthesia to complete the Study Dental Procedure, the participant is given a rescue injection of local anesthetic and is considered a failure for this outcome.
Conditions Studied
Interventions
- DRUG 400uL of Kovacaine Mist
- DRUG 200uL of Kovacaine Mist
- DRUG 120uL of Kovacaine Mist
Study Locations (1)
Colorado
- Big Grins - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
What the finished NCT01701505 record still lists
NCT01701505 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which 400uL of Kovacaine Mist is the first listed.
NCT01701505 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01701505 about?
NCT01701505 is a clinical study titled "Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects". The purpose of this study is to assess the efficacy and safety of intranasally administered Kovacaine Mist for anesthetizing maxillary teeth in pediatric subjects.
What is the current status of trial NCT01701505?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2012-10. Estimated completion is 2012-10.
What conditions does trial NCT01701505 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT01701505?
The interventions under investigation include: 400uL of Kovacaine Mist (DRUG), 200uL of Kovacaine Mist (DRUG), 120uL of Kovacaine Mist (DRUG).
Who is sponsoring clinical trial NCT01701505?
This trial is sponsored by St. Renatus, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01701505 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01701505's enrollment target sits among peer trials
48 36th of 57 higher than 21 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose-Escalation Safety and Pharmacokinetic Study of K305
COMPLETED · Phase 2
-
EEG Studies of Ketamine General Anesthesia
COMPLETED · Phase 2
-
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
COMPLETED · Phase 2
-
Investigating Near-Threshold Perception During Anesthetic Sedation
COMPLETED · Phase 2
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
- NCT03579875 · 48 participants · Phase 2
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia